Role of regulatory t cells in xenotransplantation

Current Opinion in Organ Transplantation

Volumn 15, Issue 2, 2010, Pages 224-229

  O'Connell, Philip J ^a   Yi, Shounan ^a   Carrington, Emma M ^b   Lew, Andrew M ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Regulatory T cells; Xenoimmunity; Xenotransplantation

Indexed keywords

CALCINEURIN INHIBITOR; HISTONE DEACETYLASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ALLOTRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DRUG EFFECT; HUMAN; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; RODENT; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; SPECIES SPECIFICITY; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 77952247328     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283373c27     Document Type: Review

References (63)

1. Steinmetz M, Minard K, Horvath S, et al. A molecular map of the immune response region from the major histocompatibility complex of the mouse. Nature 1982;300:35-42. (Pubitemid 12005050)
2. Shevach EM. Mechanisms of Foxp3+T regulatory cell-mediated suppression. Immunity 2009;30:636-645. An excellent review of the biology of naturally occurring Tregs.
3. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003;4:330-336.
4. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003;4:337-342.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061. (Pubitemid 36222930)
6. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, poly-endocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20-21. (Pubitemid 32044513)
7. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27:18-20. (Pubitemid 32044512)
8. Vinay DS, Kim CH, Choi BK, Kwon BS. Origins and functional basis of regulatory CD11c+CD8+ T cells. Eur J Immunol 2009;39:1552-1563.
9. Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008;9:239-244. (Pubitemid 351267321)
10. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210. (Pubitemid 37323205)
11. Hall BM, Pearce NW, Gurley KE, Dorsch SE. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 1990;171:141-157. (Pubitemid 20040605)
12. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
13. Akl A, Luo S, Wood KJ. Induction of transplantation tolerance: the potential of regulatory T cells. Transpl Immunol 2005;14:225-230. (Pubitemid 40848529)
14. Borsellino G, Kleinewietfeld M, Di Mitri D, et al. Expression of ectonucleo-tidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007;110:1225-1232. (Pubitemid 47281420)
15. DeaglioS, Dwyer KM, Gao W, et al. Adenosine generation catalyzed byCD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204:1257-1265. (Pubitemid 46919862)
16. Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL) -2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203:1693-1700. (Pubitemid 44036275)
17. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3and suppressive function of human CD4+Treg cells. J Exp Med 2006;203:1701-1711. (Pubitemid 44036276)
18. Wing K, Onishi Y, Prieto-Martin P, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008;322:271-275. This study shows that CTLA4 expressed on T regulatory cells controls their ability to dampen immune activation by antigen-presenting cells, preventing autoimmune disease.
19. + immunoregula-tory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
20. Huang CT, Workman CJ, Flies D, et al. Role of LAG-3 in regulatory T cells. Immunity 2004;21:503-513. (Pubitemid 39370506)
21. Demirkiran A, Hendrikx TK, Baan CC, van der Laan LJ. Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting? Transplantation 2008;85:783-789. (Pubitemid 351440740)
22. Gao W, Lu Y, El Essawy B, et al. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 2007;7:1722-1732. (Pubitemid 46905432)
23. Segundo DS, Ruiz JC, Izquierdo M, et al. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 2006;82:550-557.
24. Demirkiran A, Sewgobind VD, van der Weijde J, et al. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. Transplantation 2009;87:1062-1068.
25. Cobbold SP, Adams E, Farquhar CA, et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc Natl Acad Sci USA 2009;106:12055-12060. Important study showing that the ability of antigen-specific Tregs to recruit naive T cells to be regulatory cells is dependent on the activation of key enzymes that consume at least five essential amino acids leading to a lack of T-cell proliferation and induction of FoxP3.
26. - effector T cells.
27. Tao R, de Zoeten EF, Ozkaynak E, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007;13:1299-1307. (Pubitemid 350073591)
28. de Zoeten EF, Wang L, Sai H, et al. Expression of HDAC9 by T regulatory cells prevents colitis in mice. Gastroenterology, Epub ahead of print, PMID 19879272.
29. + regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice. Int Immunopharmacol 2009;9:553-563.
30. + regulatory T cells with indirect allospeci-ficity and short term immunosuppression. Transpl Immunol 2009;21:203-209.
31. Zhang GY, Hu M, Wang YM, Alexander SI. Foxp3 as a marker of tolerance induction versus rejection. Curr Opin Organ Transplant 2009;14:40-45.
32. Chauhan SK, Saban DR, Lee HK, Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol 2009;182:148-153.
33. *].
34. *]. (Pubitemid 351989494)
35. Allan SE, Passerini L, Bacchetta R, et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005;115:3276-3284. (Pubitemid 41567592)
36. Walker MR, Kasprowicz DJ, Gersuk VH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 2003;112:1437-1443.
37. Yi S, Feng X, Hawthorne WJ, et al. CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-7-dependent recruitment of macrophages and natural killer cells. Transplantation 2002;73:437-446. (Pubitemid 34174295)
38. Mirenda V, Golshayan D, Read J, et al. Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. Diabetes 2005;54:1048-1055. (Pubitemid 40446318)
39. Andres A, Toso C, Morel P, et al. Macrophage depletion prolongs discordant but not concordant islet xenograft survival. Transplantation 2005;79:543-549. (Pubitemid 40365882)
40. Rayat GR, Johnson ZA, Beilke JN, et al. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Diabetes 2003;52:1433-1440.
41. Rocha PN, Plumb TJ, Crowley SD, Coffman TM. Effector mechanisms in transplant rejection. Immunol Rev 2003;196:51-64.
42. Yi S, Hawthorne WJ, Lehnert AM, et al. T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 2003;170:2750-2758. (Pubitemid 36245670)
43. Fu Y, Lu X, Yi S, et al. Selective rejection of porcine islet xenografts by macrophages. Xenotransplantation 2008;15:307-312.
44. Chen W, Ford MS, Young KJ, Zhang L. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses. Cell Mol Immunol 2004;1:328-335.
45. Misra N, Bayry J, Lacroix-Desmazes S, et al. Human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004;172:4676-4680.
46. Zhao DM, Thornton AM, Dipaolo RJ, Shevach EM. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 2006;107:3925-3939.
47. Porter CM, Bloom ET. Human CD4+CD25+ regulatory T cells suppress antiporcine xenogeneic responses. Am J Transplant 2005;5:2052-2057.
48. Wu J, Yi S, Ouyang L, et al. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses. Transplantation 2008;85:1841-1848. A study demonstrating that CD4+CD25+ Tregs expanded in vitro were potent suppressors of antiporcine human T-cell responses using both cell contact and cytokine-mediated mechanisms.
49. Sun L, Yi S, O'Connell PJ. IL-10 is required for human CD4+CD25+ regulatory T cell-mediated suppression of xenogeneic proliferation. Immunol Cell Biol (in press). Using siRNA to suppress IL-10 gene expression, this study shows that IL-10 was necessary for Treg suppression of the antiporcine human T-cell response in vitro, whereas suppression of IL-10 production had no effect on Treg suppression of the human alloimmune T-cell response. This study shows that there was a dichotomy in the mechanisms of Treg suppression of the xenoimmune and alloimmune T-cell responses.
50. Feng X, Zheng XX, Yi S, et al. IL-10/Fc inhibits macrophage function and prolongs pancreatic islet xenograft survival. Transplantation 1999;68:1775-1783. (Pubitemid 30004811)
51. Zheng XX, Steele AW, Nickerson PW, et al. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol 1995;154:5590-5600.
52. Fu Y, Yi S, Wu J, et al. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+CD25+ regulatory T cells. Transplantation 2008;86:865-874. A study showing that human Tregs suppressed xenoantigen-primed and CD4+ T-cell-mediated macrophage activation and antigen-presenting cell function. However, Tregs had no direct effect on macrophages in vitro.
53. Chen W, Ford MS, Young KJ, et al. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003;170: 1846-1853. (Pubitemid 36197401)
54. Chen W, Zhou D, Torrealba JR, et al. Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory T cells. J Immunol 2005;175:3409-3416. (Pubitemid 41170564)
55. Chen W, Diao J, Stepkowski SM, Zhang L. Both infiltrating regulatory T cells and insufficient antigen presentation are involved in long-term cardiac xenograft survival. J Immunol 2007;179:1542-1548.
56. Zhang ZX, Ma Y, Wang H, et al. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent, Fas-Fas ligand-independent pathway. J Immunol 2006;177:6920-6929. (Pubitemid 44715058)
57. Ma Y, He KM, Garcia B, et al. Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation. Xenotransplantation 2008;15:56-63. (Pubitemid 351360242)
58. Thomson CW, Lee BP, Zhang L. Double-negative regulatory T cells: non-conventional regulators. Immunol Res 2006;35:163-178. (Pubitemid 44547511)
59. Cortesini R, LeMaoult J, Ciubotariu R, Cortesini NS. CD8+CD28-T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol Rev 2001;182:201-206. (Pubitemid 33070219)
60. Wang J, Jiang S, Shi H, et al. Prolongation of corneal xenotransplant survival by T-cell vaccination-induced T-regulatory cells. Xenotransplantation 2008;15:164-173. (Pubitemid 352000250)
61. Zeng D, Lewis D, Dejbakhsh-Jones S, et al. Bone marrow NK1.1 (-) and NK1.1 (+) T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999;189:1073-1081. (Pubitemid 29169824)
62. Ikehara Y, Yasunami Y, Kodama S, et al. CD4 (+) Valpha14 natural killerT cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000;105:1761-1767. (Pubitemid 30421757)
63. Gordon EJ, Kelkar V. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice. Xenotransplantation 2009;16:135-144.